Why Edwards Lifesciences (EW) Is Among the Best Medical Device Stocks to Buy Now

Noor Ul Ain Rehman

Fri, May 9, 2025, 4:46 AM 5 min read

We precocious published a database of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to instrumentality a look astatine wherever Edwards Lifesciences Corporation (NYSE:EW) stands against different champion aesculapian instrumentality stocks to bargain now.

On April 16, CNBC reported that Trump’s tariffs are gathering a disagreement successful the aesculapian community. The archetypal Trump medication did not enforce tariffs connected aesculapian devices and protective cogwheel manufactured successful Mexico, China, and Canada. However, the assemblage has not received a reprieve from the president’s newest circular of duties truthful far. This has resulted successful a division: since instrumentality makers could perchance look important challenges from tariffs, they are pushing backmost for a mode out. In contrast, idiosyncratic protective instrumentality manufacturers basal to payment from the barriers created by the levies, which is wherefore they are not showing signs of a propulsion back.

The aesculapian assemblage is frankincense presenting a dichotomy successful the look of tariffs. CNBC reported that the duties could besides rise costs for hospitals, and successful turn, patients, yet reducing entree to captious attraction and equipment. Scott Whitaker, CEO of AdvaMed, the commercialized radical representing aesculapian exertion and instrumentality makers, said the pursuing astir the situation:

“MedTech proviso concatenation leaders are already reporting proviso concatenation concerns, and we cannot spend to thrust up the outgo of wellness attraction for patients, oregon connected the wellness attraction system. The world is, immoderate accrued costs volition beryllium mostly borne by taxpayer-funded wellness programs similar Medicare, Medicaid, and the VA.”

Hospital commercialized groups are besides voicing their concerns, informing that tariffs could bring the prime of attraction down. CNBC reported that Rick Pollack, the CEO of the American Hospital Association, opined:

“The AHA has and volition proceed to stock with the Administration, disruptions successful the availability of these captious devices — galore of which are sourced internationally — person the imaginable to disrupt diligent care. AHA continues to propulsion for a tariff exemption for aesculapian devices to guarantee that hospitals and wellness systems tin proceed to service their patients and communities.”

READ ALSO: Recession Resistant Investing: 10 Best Grocery Stocks To Buy Now and 11 Most Promising Future Stocks According to Hedge Funds.

President Trump imposed a 25% tariff connected imported goods from Mexico and Canada successful February, aboriginal delaying levies connected a fig of items falling nether the US-Mexico-Canada Agreement. However, Chinese goods person not seen immoderate reprieve. In fact, the caller levies imposed successful Trump’s 2nd word person brought the full tariff complaint up to 145%. While a mode retired of the contiguous conditions is to rise prices to offset the rising expenses from tariffs, a scope of hospitals and different organizations buying aesculapian instrumentality cannot bash so. These institutions are frankincense apt to look complications passing connected higher costs nether the existent security sum contracts with locked-in yearly prices.